FDA Oncology Announcements

HDAC inhibitor × Lymphoid × Clear all

3 Announcements

Belinostat

Drug: BELEODAQ (belinostat) · HDAC inhibitor
Condition: Lymphoid

Romidepsin

Drugs: ISTODAX (romidepsin) · HDAC inhibitor, ISTODAX (injection)
Condition: Lymphoid

FDA approves vorinostat (Zolinza) for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma (CTCL)

Drug: Zolinza (vorinostat) · HDAC inhibitor
Condition: Lymphoid